ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,411Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 1571

$1.08M Total Retail Price of All Prescriptions

Rank: 50 out of 1571

582 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 582 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 14,046 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $99 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ATENOLOL 1,000 971 1 15
WARFARIN SODIUM 715 665 2 14
DIOVAN 643 623 3 19
CLONIDINE HCL 574 574 4 45
AMLODIPINE BESYLATE 570 555 5 2
ATORVASTATIN CALCIUM 516 504 6 8
BENICAR 424 424 7 148
PLAVIX 379 376 8 28
HYDROCHLOROTHIAZIDE 373 358 9 18
METFORMIN HCL 334 332 10 9
CLOPIDOGREL 288 282 11 21
CRESTOR 280 279 12 25
METOPROLOL TARTRATE 278 268 13 13
CELEBREX 221 213 14 71
LOVASTATIN 217 211 15 33
LISINOPRIL 210 205 16 5
ALENDRONATE SODIUM 209 209 17 22
CARVEDILOL 190 175 18 10
BENAZEPRIL HCL 173 146 19 32
ZOLPIDEM TARTRATE 160 158 20 20
TAMSULOSIN HCL 156 152 21 11
RAMIPRIL 147 137 22 94
SIMVASTATIN 138 135 23 1
LOSARTAN POTASSIUM 137 133 24 17
FELODIPINE ER 129 116 25 260
LIPITOR 127 121 26 67
JANUVIA 125 125 27 50
ISOSORBIDE MONONITRATE ER 115 115 28 48
DOXAZOSIN MESYLATE 112 112 29 84
ALLOPURINOL 110 110 30 36
GLIMEPIRIDE 110 108 30 70
LIDODERM 108 108 32 95
NEXIUM 107 107 33 39
PROAIR HFA 107 107 33 63
AMLODIPINE BESYLATE-BENAZEPRIL 101 101 35 135
COUMADIN 101 101 35 294
AZITHROMYCIN 99 96 37 58
OMEPRAZOLE 98 98 38 4
ACTONEL 97 97 39 171
METOPROLOL SUCCINATE 97 97 39 16
NAPROXEN 92 92 41 98
AMIODARONE HCL 92 92 41 76
RANITIDINE HCL 91 91 43 85
NITROSTAT 87 87 44 134
SOTALOL 85 71 45 157
GLYBURIDE-METFORMIN HCL 82 82 R 46 178
AMOXICILLIN 76 76 47 192
BYSTOLIC 74 74 48 144
TEKTURNA 72 72 49 312
ACTOS 72 72 49 92
NASONEX 70 70 51 163
DIGOXIN 70 70 51 35
WELCHOL 69 69 53 258
DONEPEZIL HCL 68 68 54 24
LEVOTHYROXINE SODIUM 68 65 54 6
LANTUS 65 49 56 65
MECLIZINE HCL 64 64 57 162
COLCRYS 64 64 57 289
ADVAIR DISKUS 61 61 59 43
FUROSEMIDE 60 60 60 7
EXFORGE 59 59 61 280
PANTOPRAZOLE SODIUM 57 57 62 23
BENICAR HCT 54 54 63 302
NIFEDIPINE ER 53 53 64 78
LACTULOSE 51 51 65 196
GUANFACINE HCL 50 50 R 66 633
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.